Michael D. Shapiro

Active 1899–2026

Also published as
MICHAEL D. SHAPIRO
199
Papers
19,190
Citations
74
h-index
165
i10-index

Citations

Citations per year for Michael D. Shapiro1973: 1 citations1977: 1 citations1978: 1 citations1980: 2 citations1985: 1 citations1986: 3 citations1987: 4 citations1988: 8 citations1989: 1 citations1990: 2 citations1991: 3 citations1992: 6 citations1994: 1 citations1995: 4 citations1996: 1 citations1997: 1 citations1998: 6 citations1999: 9 citations2000: 17 citations2001: 20 citations2002: 16 citations2003: 26 citations2004: 26 citations2005: 46 citations2006: 62 citations2007: 77 citations2008: 91 citations2009: 104 citations2010: 141 citations2011: 138 citations2012: 85 citations2013: 103 citations2014: 100 citations2015: 102 citations2016: 99 citations2017: 92 citations2018: 95 citations2019: 289 citations2020: 480 citations2021: 581 citations2022: 518 citations2023: 492 citations2024: 971 citations2025: 758 citations2026: 62 citations1974–1976: no citations, so these years are not shown1979: no citations, so this year is not shown1981–1984: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,193 citing papers, 24% of this breakdownChina: 823 citing papers, 9% of this breakdownUnited Kingdom: 635 citing papers, 7% of this breakdownItaly: 443 citing papers, 4.9% of this breakdownCanada: 427 citing papers, 4.7% of this breakdownGermany: 408 citing papers, 4.5% of this breakdownAustralia: 294 citing papers, 3.2% of this breakdownNetherlands: 255 citing papers, 2.8% of this breakdownFrance: 238 citing papers, 2.6% of this breakdownSpain: 236 citing papers, 2.6% of this breakdownJapan: 203 citing papers, 2.2% of this breakdownSwitzerland: 199 citing papers, 2.2% of this breakdown
0%24%Other 30.3%

Fields

  • Medicine61.4%
  • Biochemistry, Genetics and Molecular Biology26%
  • Agricultural and Biological Sciences3%
  • Immunology and Microbiology2.2%
  • Environmental Science1.8%
  • Neuroscience0.8%
  • Other4.8%

Topics

  • Lipoproteins and Cardiovascular Health8.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.9%
  • Cardiac Imaging and Diagnostics2.9%
  • Genetic diversity and population structure2.9%
  • Atherosclerosis and Cardiovascular Diseases2.4%
  • Cancer, Lipids, and Metabolism1.8%
  • Other76.8%

Coauthors

All papers

Open in search
  1. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,002

  2. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk

    Authors: , , , - Endocrine Reviews 2018 cited by 601

  3. Global burden of metabolic diseases, 1990–2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 cited by 302

  4. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jang Won Son, John Ryan, Ignatios Ikonomidis, Sombat Treeprasertsuk, Daniele Pastori, Monica Lupșor‐Platon, Herbert Tilg, Hasmik Ghazinyan, Jérôme Boursier, Masahide Hamaguchi, Mindie H. Nguyen, Jian‐Gao Fan, George Boon‐Bee Goh, Mamun Al Mahtab, Saeed Hamid, Nilanka Perera, Jacob George, Ming‐Hua Zheng - Hepatology International 2023 cited by 183

  5. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2021 cited by 202

  6. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

    Authors: , , , , , , , , , , , - Cardiovascular Diabetology 2022 cited by 158

  7. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

    Authors: , , , , , , , - American Journal of Preventive Cardiology 2022 cited by 280

  8. Apolipoproteins in vascular biology and atherosclerotic disease

    Authors: , - Nature Reviews Cardiology 2021 cited by 256

  9. Ten things to know about ten cardiovascular disease risk factors

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Preventive Cardiology 2021 cited by 259

  10. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 157

  11. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a)

    Authors: , , , , , , , - Journal of the American College of Cardiology 2021 cited by 160

  12. PCSK9

    Authors: , , - Circulation Research 2018 cited by 285

  13. Adaptive Evolution of Pelvic Reduction in Sticklebacks by Recurrent Deletion of a Pitx1 Enhancer

    Authors: , , , , , , , , , , , , , , , - Science 2009 cited by 1,074

  14. Coronary Atherosclerosis in an Asymptomatic U.S. Population

    Authors: , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2022 cited by 84

  15. Dual‐Energy X‐Ray Absorptiometry for Quantification of Visceral Fat

    Authors: , , , , , , - Obesity 2012 cited by 630

  16. The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

    Authors: , , , - Frontiers in Cardiovascular Medicine 2020 cited by 184

  17. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States

    Authors: , , , , , , , - Journal of the American College of Cardiology 2024 cited by 86

  18. Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both

    Authors: , , , , - Journal of Hepatology 2024 cited by 40

  19. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

    Authors: , , - American Journal of Preventive Cardiology 2022 cited by 115

  20. Personalized Intervention Based on Early Detection of Atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 cited by 70

  21. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriele Hanauer-Mader, Mariko Harada‐Shiba, G. E. Hastings, G. Kees Hovingh, Maria Cristina de Oliveira Izar, Allison Jamison, Gunnar N. Karlsson, Meral Kayıkçıoğlu, Sue Koob, Masahiro Koseki, Stacey Lane, Marcos M. Lima-Martínez, Greizy López, Tânia Leme da Rocha Martinez, David Marais, Letrillart Marion, Pedro Mata, Inese Maurina, Diana Maxwell, Roopa Mehta, George A. Mensah, André R. Miserez, Dermot Neely, Stephen J. Nicholls, Atsushi Nohara, Børge G. Nordestgaard, Leiv Ose, Athanasios Pallidis, Jing Pang, Jules Payne, Amy L. Peterson, Monica P. Popescu, Raman Puri, Kausik K. Ray, Ashraf Reda, Tiziana Sampietro, Raúl D. Santos, Inge Schalkers, Laura Schreier, Michael D. Shapiro, Eric J.G. Sijbrands, Daniel Soffer, Claudia Stefanutti, Mario Stoll, Rody G. Sy, Marta Lucía Tamayo, Myra Tilney, Lâle Tokgözoğlu, Brian Tomlinson, Antonio J. Vallejo‐Vaz, Alejandra Vázquez-Cárdenas, Patrícia Vieira de Luca, David S Wald, Gerald F. Watts, Nanette K. Wenger, M. Allison Wolf, David Wood, Aram Zegerius, Thomas A. Gaziano, Samuel S. Gidding - JAMA Cardiology 2020 cited by 258

  22. Inflammation and Cardiovascular Disease: The Future

    Authors: , , , , - European Cardiology Review 2021 cited by 87

  23. IL-6 and Cardiovascular Risk: A Narrative Review

    Authors: , , - Current Atherosclerosis Reports 2024 cited by 86

  24. Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study

    Authors: , , , , , , , , - European Journal of Preventive Cardiology 2024 cited by 44